INMUNE BIO INC. (INMB) Operating Margin
- Operating margin · 12 months: Value (m); Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | (m) | Operating income / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | -20.20M USD | Operating Income (Loss) |
| Revenue | (m) | |
| Cost of products and services | (m) | |
| Research and development | (m) | Research and Development Expense |
| Selling, general and administration | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $-20.20M | (m) | (m) | (m) | (m) | (m) |
| 2026-03-31 | $-43.29M | (m) | (m) | $16.66M | (m) | (m) |
| 2025-12-31 | $-47.38M | $50.00K | (m) | $20.66M | (m) | -94766.00% |
| 2025-09-30 | $-51.38M | $50.00K | (m) | $25.68M | (m) | -102752.00% |
| 2025-06-30 | $-56.23M | $50.00K | (m) | $30.86M | (m) | -112458.00% |
| 2025-03-31 | $-41.52M | $50.00K | (m) | $32.11M | (m) | -83046.00% |
| 2024-12-31 | $-42.63M | $14.00K | (m) | $33.17M | (m) | -304535.71% |
| 2024-09-30 | $-41.55M | $42.00K | (m) | $31.82M | (m) | -98921.43% |
| 2024-06-30 | $-37.79M | $85.00K | (m) | $27.74M | (m) | -44457.65% |
| 2024-03-31 | $-34.34M | $131.00K | (m) | $24.83M | (m) | -26209.92% |
| 2023-12-31 | $-29.74M | $155.00K | (m) | $20.27M | (m) | -19187.74% |
| 2023-09-30 | $-27.00M | $224.00K | (m) | $17.68M | (m) | -12055.36% |
| 2023-06-30 | $-25.92M | $279.00K | (m) | $16.85M | (m) | -9289.96% |
| 2023-03-31 | $-25.90M | $249.00K | (m) | $16.89M | (m) | -10400.00% |
| 2022-12-31 | $-25.95M | $374.00K | (m) | $17.07M | (m) | -6938.77% |
| 2022-09-30 | $-29.34M | $440.00K | (m) | $20.73M | (m) | -6667.95% |
| 2022-06-30 | $-30.92M | $356.00K | (m) | $22.09M | (m) | -8684.55% |
| 2022-03-31 | $-31.08M | $340.00K | (m) | $22.36M | (m) | -9142.06% |
| 2021-12-31 | $-29.15M | $181.00K | (m) | $20.54M | (m) | -16106.63% |
| 2021-09-30 | $-23.33M | (m) | (m) | $15.33M | (m) | (m) |
| 2021-06-30 | $-19.13M | (m) | (m) | $11.18M | (m) | (m) |
| 2021-03-31 | $-14.68M | (m) | (m) | $7.62M | (m) | (m) |
| 2020-12-31 | $-12.23M | $10.92K | (m) | $5.92M | (m) | -112016.09% |
| 2020-09-30 | $-11.35M | (m) | (m) | $4.93M | (m) | (m) |
| 2020-06-30 | $-9.62M | (m) | (m) | $3.73M | (m) | (m) |
| 2020-03-31 | $-7.94M | (m) | (m) | $3.46M | (m) | (m) |
| 2019-12-31 | $-7.76M | (m) | (m) | $3.28M | (m) | (m) |
| 2019-09-30 | $-7.30M | (m) | (m) | $1.16M | (m) | (m) |
| 2019-06-30 | $-5.76M | $0.00 | (m) | $1.11M | (m) | (m) |
| 2019-03-31 | $-11.50M | $0.00 | (m) | $1.10M | (m) | (m) |
| 2018-12-31 | $-12.44M | $0.00 | (m) | $1.11M | (m) | (m) |
| 2018-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-12-31 | $-981.48K | $0.00 | (m) | $435.36K | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B |